PE20142315A1 - Triterpenoides de c-3 cicloalquenilo con actividad inhibidora de la maduracion del virus del vih - Google Patents
Triterpenoides de c-3 cicloalquenilo con actividad inhibidora de la maduracion del virus del vihInfo
- Publication number
- PE20142315A1 PE20142315A1 PE2014001279A PE2014001279A PE20142315A1 PE 20142315 A1 PE20142315 A1 PE 20142315A1 PE 2014001279 A PE2014001279 A PE 2014001279A PE 2014001279 A PE2014001279 A PE 2014001279A PE 20142315 A1 PE20142315 A1 PE 20142315A1
- Authority
- PE
- Peru
- Prior art keywords
- alkyl
- inhibiting activity
- hiv virus
- cycloalkenyl
- virus maturation
- Prior art date
Links
- 230000002401 inhibitory effect Effects 0.000 title 1
- 150000003648 triterpenes Chemical class 0.000 title 1
- 230000029302 virus maturation Effects 0.000 title 1
- -1 TRITERPENOID COMPOUND Chemical class 0.000 abstract 5
- 239000002253 acid Substances 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 2
- QUPDWYMUPZLYJZ-UHFFFAOYSA-N ethyl Chemical class C[CH2] QUPDWYMUPZLYJZ-UHFFFAOYSA-N 0.000 abstract 2
- 208000030507 AIDS Diseases 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 230000035800 maturation Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
- C07J53/002—Carbocyclic rings fused
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261599040P | 2012-02-15 | 2012-02-15 | |
| US13/760,726 US8906889B2 (en) | 2012-02-15 | 2013-02-06 | C-3 cycloalkenyl triterpenoids with HIV maturation inhibitory activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20142315A1 true PE20142315A1 (es) | 2015-01-16 |
Family
ID=48946098
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2014001279A PE20142315A1 (es) | 2012-02-15 | 2013-02-13 | Triterpenoides de c-3 cicloalquenilo con actividad inhibidora de la maduracion del virus del vih |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US8906889B2 (enExample) |
| EP (1) | EP2814834B1 (enExample) |
| JP (1) | JP6155285B2 (enExample) |
| KR (1) | KR20140123584A (enExample) |
| CN (2) | CN104220451B (enExample) |
| AR (1) | AR089996A1 (enExample) |
| AU (1) | AU2013221725B2 (enExample) |
| BR (1) | BR112014019672A8 (enExample) |
| CA (1) | CA2864656A1 (enExample) |
| CL (1) | CL2014002141A1 (enExample) |
| CO (1) | CO7061077A2 (enExample) |
| EA (1) | EA024361B1 (enExample) |
| ES (1) | ES2656984T3 (enExample) |
| HK (1) | HK1204608A1 (enExample) |
| IL (1) | IL234077A (enExample) |
| MX (1) | MX2014009235A (enExample) |
| MY (1) | MY166793A (enExample) |
| NZ (1) | NZ631408A (enExample) |
| PE (1) | PE20142315A1 (enExample) |
| PH (1) | PH12014501816A1 (enExample) |
| PT (1) | PT2814834T (enExample) |
| SG (1) | SG11201404748XA (enExample) |
| TW (1) | TW201336863A (enExample) |
| UY (1) | UY34627A (enExample) |
| WO (1) | WO2013123019A1 (enExample) |
| ZA (1) | ZA201406724B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
| KR20150115881A (ko) | 2013-02-06 | 2015-10-14 | 브리스톨-마이어스 스큅 컴퍼니 | Hiv 성숙 억제 활성을 갖는 c-19 변형된 트리테르페노이드 |
| HRP20201645T1 (hr) | 2014-04-11 | 2020-12-25 | VIIV Healthcare UK(No.4) Limited | Triterpenoidi s aktivnošću inhibiranja zrenja hiv, supstituirani na položaju 3 nearomatskim prstenom koji nosi halogenalkilni supstituent |
| US9920090B2 (en) | 2014-06-19 | 2018-03-20 | VIIV Healthcare UK (No.5) Limited | Betulinic acid derivatives with HIV maturation inhibitory activity |
| EP3218388A1 (en) | 2014-11-14 | 2017-09-20 | VIIV Healthcare UK (No.5) Limited | C17-aryl substituted betulinic acid analogs |
| JP6620149B2 (ja) * | 2014-11-14 | 2019-12-11 | ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド | 拡張ベツリン酸類似体 |
| WO2016077561A1 (en) | 2014-11-14 | 2016-05-19 | Bristol-Myers Squibb Company | Oxolupene derivatives |
| KR20170135970A (ko) * | 2015-04-14 | 2017-12-08 | 비브 헬스케어 유케이 (넘버4) 리미티드 | Hiv 성숙화 억제제를 생산하는 방법 |
| CN108026140A (zh) * | 2015-07-28 | 2018-05-11 | 葛兰素史克知识产权第二有限公司 | 用于预防或治疗hiv感染的白桦脂醇衍生物 |
| RU2018105352A (ru) | 2015-07-28 | 2019-08-29 | ГлаксоСмитКлайн Интеллекчуал Проперти (N2) Лимитед | Производные бетулина для предупреждения или лечения ВИЧ-инфекций |
| EP3353158A1 (en) | 2015-09-24 | 2018-08-01 | Glaxosmithkline Intellectual Property (No. 2) Limited | Compounds with hiv maturation inhibitory activity |
| BR112018014622A2 (pt) * | 2016-01-20 | 2018-12-11 | Glaxosmithkline Ip No 2 Ltd | ?composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, métodos para tratar uma infecção por hiv e para prevenir uma infecção por hiv, e, uso de um composto ou sal? |
| AR107512A1 (es) | 2016-02-04 | 2018-05-09 | VIIV HEALTHCARE UK Nº 5 LTD | Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1 |
| CN106905264B (zh) * | 2017-04-12 | 2019-06-07 | 连云港杰瑞药业有限公司 | 一种合成阿扎拉韦中间体的方法 |
| EP3681507B8 (en) | 2017-09-13 | 2024-03-13 | Emmyon, Inc. | Ursolic acid morpholine and diethanolamine salts |
| PT3784349T (pt) | 2018-04-24 | 2024-01-22 | Viiv Healthcare Uk No 5 Ltd | Compostos com atividade inibidora de maturação do hiv |
| CN109705189B (zh) * | 2018-12-29 | 2020-06-05 | 中国医学科学院药用植物研究所 | 具有式i所示结构的三萜衍生物及其制备方法和应用 |
| PL3924361T3 (pl) | 2019-02-11 | 2024-03-18 | Hetero Labs Limited | Nowe pochodne triterpenu jako inhibitory wirusa hiv |
| WO2020229398A1 (de) | 2019-05-14 | 2020-11-19 | Bayer Aktiengesellschaft | (1-alkenyl)-substituierte pyrazole und triazole als schädlingsbekämpfungsmittel |
Family Cites Families (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5413999A (en) | 1991-11-08 | 1995-05-09 | Merck & Co., Inc. | HIV protease inhibitors useful for the treatment of AIDS |
| US5869535A (en) | 1995-03-21 | 1999-02-09 | The Board Of Trustees Of The University Of Illinois | Method and composition for selectively inhibiting melanoma |
| US5962527A (en) | 1995-03-21 | 1999-10-05 | The Board Of Trustees Of The University Of Illinois | Method and composition for treating cancers |
| US5679828A (en) | 1995-06-05 | 1997-10-21 | Biotech Research Labs, Inc. | Betulinic acid and dihydrobetulinic acid derivatives and uses therefor |
| US20040110785A1 (en) | 2001-02-02 | 2004-06-10 | Tao Wang | Composition and antiviral activity of substituted azaindoleoxoacetic piperazine derivatives |
| US7365221B2 (en) | 2002-09-26 | 2008-04-29 | Panacos Pharmaceuticals, Inc. | Monoacylated betulin and dihydrobetulin derivatives, preparation thereof and use thereof |
| WO2004089357A2 (en) | 2003-04-02 | 2004-10-21 | Regents Of The University Of Minnesota | Anti-fungal formulation of triterpene and essential oil |
| US7745625B2 (en) | 2004-03-15 | 2010-06-29 | Bristol-Myers Squibb Company | Prodrugs of piperazine and substituted piperidine antiviral agents |
| CA2560266A1 (en) | 2004-03-17 | 2005-09-29 | Panacos Pharmaceuticals, Inc. | Pharmaceutical salts of 3-o-(3',3'-dimethylsuccinyl) betulinic acid |
| TW200628161A (en) | 2004-11-12 | 2006-08-16 | Panacos Pharmaceuticals Inc | Novel betulin derivatives, preparation thereof and use thereof |
| WO2008127364A2 (en) | 2006-10-13 | 2008-10-23 | Myriad Genetics, Inc. | Antiviral compounds and use thereof |
| WO2008115281A2 (en) | 2006-10-16 | 2008-09-25 | Myriad Genetics, Inc. | Compounds for treating viral infections |
| US20090062243A1 (en) | 2007-08-03 | 2009-03-05 | Advanced Life Sciences, Inc. | Lupane-Type Triterpenoids Modified at 30-Position and Analogues Thereof |
| CN101981047A (zh) * | 2008-01-03 | 2011-02-23 | Viro化学制药公司 | 新的羽扇烷衍生物 |
| EP2257567A1 (en) | 2008-02-14 | 2010-12-08 | Virochem Pharma Inc. | Novel 17 beta lupane derivatives |
| US9067966B2 (en) | 2009-07-14 | 2015-06-30 | Hetero Research Foundation, Hetero Drugs Ltd. | Lupeol-type triterpene derivatives as antivirals |
| US8759366B2 (en) | 2009-12-17 | 2014-06-24 | Merck Sharp & Dohme Corp. | Aminopyrimidines as SYK inhibitors |
| CA2801487C (en) * | 2010-06-04 | 2017-12-05 | Bristol-Myers Squibb Company | Modified c-3 betulinic acid derivatives as hiv maturation inhibitors |
| DK2576586T3 (en) * | 2010-06-04 | 2015-11-23 | Bristol Myers Squibb Co | C-28 AMINES OF MODIFIED C-3-BETULIN ACID DERIVATIVES AS ANTI-HUMIDITY INHIBITORS |
| JP5984218B2 (ja) | 2010-07-02 | 2016-09-06 | ギリアード サイエンシーズ， インコーポレイテッド | Ａｉｄｓを処置するためのナフト−２−イル酢酸誘導体 |
| DK2670764T3 (en) * | 2011-01-31 | 2015-12-07 | Bristol Myers Squibb Co | C-28 AMINES OF MODIFIED C-3-BETULIN ACID DERIVATIVES AS ANTI-HUMIDITY INHIBITORS |
| CN103429607B (zh) * | 2011-01-31 | 2016-02-17 | 百时美施贵宝公司 | 具有hiv成熟抑制活性的c-17和c-3经修饰的三萜系化合物 |
| TW201317255A (zh) | 2011-09-21 | 2013-05-01 | 必治妥美雅史谷比公司 | 具抗病毒活性之新穎樺木酸衍生物 |
| US8889854B2 (en) | 2012-05-07 | 2014-11-18 | Bristol-Myers Squibb Company | C-17 bicyclic amines of triterpenoids with HIV maturation inhibitory activity |
| KR20150115881A (ko) * | 2013-02-06 | 2015-10-14 | 브리스톨-마이어스 스큅 컴퍼니 | Hiv 성숙 억제 활성을 갖는 c-19 변형된 트리테르페노이드 |
-
2013
- 2013-02-06 US US13/760,726 patent/US8906889B2/en active Active
- 2013-02-08 TW TW102105203A patent/TW201336863A/zh unknown
- 2013-02-13 HK HK15105069.8A patent/HK1204608A1/xx unknown
- 2013-02-13 SG SG11201404748XA patent/SG11201404748XA/en unknown
- 2013-02-13 PT PT137074936T patent/PT2814834T/pt unknown
- 2013-02-13 EP EP13707493.6A patent/EP2814834B1/en active Active
- 2013-02-13 MY MYPI2014702277A patent/MY166793A/en unknown
- 2013-02-13 PE PE2014001279A patent/PE20142315A1/es not_active Application Discontinuation
- 2013-02-13 AU AU2013221725A patent/AU2013221725B2/en not_active Ceased
- 2013-02-13 KR KR1020147025339A patent/KR20140123584A/ko not_active Ceased
- 2013-02-13 BR BR112014019672A patent/BR112014019672A8/pt not_active Application Discontinuation
- 2013-02-13 NZ NZ631408A patent/NZ631408A/en not_active IP Right Cessation
- 2013-02-13 CN CN201380019696.6A patent/CN104220451B/zh not_active Expired - Fee Related
- 2013-02-13 CA CA2864656A patent/CA2864656A1/en not_active Abandoned
- 2013-02-13 EA EA201491531A patent/EA024361B1/ru not_active IP Right Cessation
- 2013-02-13 MX MX2014009235A patent/MX2014009235A/es unknown
- 2013-02-13 WO PCT/US2013/025897 patent/WO2013123019A1/en not_active Ceased
- 2013-02-13 CN CN201610397768.6A patent/CN106046106A/zh active Pending
- 2013-02-13 JP JP2014557739A patent/JP6155285B2/ja active Active
- 2013-02-13 ES ES13707493.6T patent/ES2656984T3/es active Active
- 2013-02-14 UY UY0001034627A patent/UY34627A/es not_active Application Discontinuation
- 2013-02-14 AR ARP130100466A patent/AR089996A1/es unknown
-
2014
- 2014-08-12 PH PH12014501816A patent/PH12014501816A1/en unknown
- 2014-08-12 IL IL234077A patent/IL234077A/en not_active IP Right Cessation
- 2014-08-13 CL CL2014002141A patent/CL2014002141A1/es unknown
- 2014-08-28 CO CO14189685A patent/CO7061077A2/es unknown
- 2014-09-12 ZA ZA2014/06724A patent/ZA201406724B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20142315A1 (es) | Triterpenoides de c-3 cicloalquenilo con actividad inhibidora de la maduracion del virus del vih | |
| PE20161391A1 (es) | Triterpenoides con actividad inhibidora de la maduracion del vih | |
| ECSP18069924A (es) | Compuestos tetracíclicos de piridona como antivirales | |
| MX2012015097A (es) | Derivados de acido naft-2-ilacetico para tratar sida. | |
| PE20141152A1 (es) | Triterpenoides c-17 y c-3 modificados con actividad inhibidora de la maduracion del virus de inmunodeficiencia humana | |
| NZ630222A (en) | 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof | |
| GT201300253A (es) | Preparacion de gadobutrol de alta pureza | |
| EA028928B9 (ru) | 2'-замещенные карбануклеозидные аналоги для противовирусного лечения | |
| ECSP13013021A (es) | Compuestos de benzotiazol y su uso farmacéutico | |
| PH12015502839A1 (en) | Antiviral compounds | |
| ECSP14013217A (es) | 4-imidazopiridazin-1-il-benzamidas y 4-imidazotriazin-1-il-benzamidas como inhibidores de btk. | |
| PE20151326A1 (es) | Composiciones farmaceuticas que comprenden derivados de betulina | |
| PH12015502459A1 (en) | 2,2-difluoropropionamide derivatives of bardoxolone methyl, polymorphic forms and methods of use thereof | |
| DOP2012000243A (es) | Compuestos de sililo tricíclicos fusionados y uso de los mismos en la fabricación de medicamentos útiles en el tratamiento de enfermedades virales | |
| BR112013006722A2 (pt) | profármaco de derivado de carbamoilpiridona policíclica substituída | |
| SG194681A1 (en) | Subsituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating hcv infections | |
| IN2014CN03113A (enExample) | ||
| MX2015010354A (es) | Derivados de acido betulinico modificados con aquilo c-3 y alquenilo utiles en el tratamiento de virus de inmunodeficiencia humana (vih). | |
| EA201190234A1 (ru) | Новые амидные производные стероидных соединений [3,2-c]пиразолов с глюкокортикоидной активностью | |
| MX346143B (es) | Ligandos del receptor ep1. | |
| MX2014002936A (es) | Nuevos derivados de acido betulinico con actividad antiviral. | |
| IN2014CN03919A (enExample) | ||
| CR20160178A (es) | Derivados de desoxinojirimicina y sus métodos de uso | |
| PE20181355A1 (es) | Triterpenoides modificados en c-3 y c-17 como inhibidores del vih-1 | |
| MX340098B (es) | Derivados de fenil-isoxazol y procedimiento para la preparacion de los mismos. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD | Application declared void or lapsed |